EP2788469A1 - Single-step method and device for the generation of stratified tubular tissue substitutes - Google Patents
Single-step method and device for the generation of stratified tubular tissue substitutesInfo
- Publication number
- EP2788469A1 EP2788469A1 EP12813142.2A EP12813142A EP2788469A1 EP 2788469 A1 EP2788469 A1 EP 2788469A1 EP 12813142 A EP12813142 A EP 12813142A EP 2788469 A1 EP2788469 A1 EP 2788469A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- culture
- porous membrane
- stratified
- cavities
- tubular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M21/00—Bioreactors or fermenters specially adapted for specific uses
- C12M21/08—Bioreactors or fermenters specially adapted for specific uses for producing artificial tissue or for ex-vivo cultivation of tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/02—Form or structure of the vessel
- C12M23/12—Well or multiwell plates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/34—Internal compartments or partitions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M23/00—Constructional details, e.g. recesses, hinges
- C12M23/46—Means for fastening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M25/00—Means for supporting, enclosing or fixing the microorganisms, e.g. immunocoatings
- C12M25/02—Membranes; Filters
Definitions
- the present invention is related to the manufacturing of stratified and tubular tissue substitutes for the replacement/regeneration of composite animal or human tissues, which may have been previously damaged by means of disease or trauma.
- the present invention describes a device which enables the simultaneous culture of multiple and different cellular types into porous membranes, as well as the method to manufacture stratified tubular tissue substitutes from those porous membranes cultured with multiple different cellular types.
- Live tissues are assemblies of cells arranged in a specific organized fashion. In some cases, cells are all structurally and functionally alike, forming simple tissues (e.g. cartilage, epithelial and adipose tissues). However, most tissues in the human body contain a mixture of cells with distinctive functions, which may be termed compound tissues (e.g. bone, skin, nervous and vascular tissues. Cells that form tissues can be divided into parenchymal
- Support cells comprise a set of highly developed cell types with complex metabolic functions and produce an extracellular matrix (ECM) , which largely defines the physical characteristics of a tissue.
- ECM extracellular matrix
- the support cells together with ECM are organized in an elaborate and hierarchical order to achieve multi-scale functions and to mutually regulate the cellular activity by soluble bioactive molecules, cell-cell direct contact, or cell-ECM interaction. This elaborate structure also provides individual cells with different microenvironments, where cells experience specific cues and show corresponding responses towards tissue function.
- Tissue Engineering has been recognized, for some time, as a promising alternative to the use of autografts or allografts for tissue reconstruction and regeneration.
- This approach utilizes cells, biomaterial scaffolds and signaling molecules for the repair of diseased or damaged tissues.
- biomaterial scaffolds are designed to support cell and tissue growth, aiming at a macroscopic level to be compatible with the
- the in vivo microenvironment for each cell type varies from tissue to tissue and from site to site, and this variation provides and conveys specific cues to cells for specific functions. Besides the recognized complex hierarchical organization, cells in tissues constantly experience mechanical stimuli. Therefore, culturing cells in the appropriate biochemical environment and in the presence of mechanical stimuli will provide a more realistic extracellular microenvironment and, consequently, will improve cell-cell and cell-matrix interactions.
- Various developed bioreactor systems introduce convective flow of the medium to perfuse in vitro-grown 3D tissue
- the present invention describes a device, which enables the simultaneous culture of multiple and different cellular types into porous membranes as well as the method to fabricate stratified tubular tissue substitutes from those porous membranes cultured with multiple different cellular types.
- the device herein described allows to separately seeding and culture multiple and different cell types into separate areas of one same porous membrane.
- the device allows delimitating multiple watertight areas on the surface of porous membranes by compression of those same membranes over specific zones. This compression is carried out by placing the membrane in between a lower rectangular plate and a malleable part, which defines
- This malleable part is in turn compressed against the porous membrane and the lower rectangular plate by means of a third part which is screwed to the lower rectangular plate.
- the malleable part which is part of this device, can be closed, making the cavities that it delimitates closed, or open, making the cavities that it delimitates open to contact with the exterior by means of upper apertures.
- tubular structures are used, which pierce the walls of the malleable part and connect each of the cavities to the exterior.
- This device in particular in its closed configuration, can be integrated into a dynamic cell culture system able to automatically seed the porous membrane's separate areas, which are delimitated by the device' s culture cavities as well as to renew the culture medium inside those cavities.
- this device allows as well for the observation of the interior of the internal chambers through the walls of its parts.
- the device can as well be easily sterilized by chemical or thermal methodologies.
- the method herein described enables the construction of stratified tubular tissue substitutes by resorting to porous membranes possessing specific zones of their surfaces seeded with multiple and different cell types.
- the method herein described consists of rolling a porous membrane, which is seeded with multiple and different cell types, around a porous rolling structure. This rolling is started in the extremity of the porous membrane containing the cell type that should be situated in the more internal layer of the stratified tubular tissue substitute and finalized in the extremity containing the cell type which should be located in the tissue substitute's most external layers.
- the method herein described is finalized after a culture period, which allows for the adhesion of cells to the surfaces of adjacent membranes.
- a stratified tubular tissue substitute is generated.
- Figure 1 shows in exploded isometric view the device in closed configuration.
- Figure 2 shows in isometric view the assembled device in closed configuration.
- Figure 3 shows in isometric view a partial section of the assembled device in closed configuration.
- Figure 4 shows a longitudinal section of the device in closed configuration.
- Figure 5 shows a transversal section of the device in closed configuration.
- Figure 6 shows in exploded isometric view the device in open configuration.
- Figure 7 shows in isometric view the assembled device in open configuration.
- Figure 8 shows in isometric view a partial section of the assembled device in open configuration .
- Figure 9 shows longitudinal section of the device in open configuration.
- FIG. 10 shows a transversal section of the device in open configuration.
- Figure 11 shows the device in closed configuration integrated into a complete dynamic cell culture system.
- Figure 12 shows the porous membrane and rolling structure before rolling the porous membrane containing three different cellular populations over its surface in order to generate a stratified tubular structure .
- Figure 13 shows the porous membrane partially rolled around the rolling structure in order to generate a stratified tubular structure.
- Figure 14 shows the porous membrane totally rolled around the rolling structure.
- Figure 15 shows a transversal section of the porous membrane rolled around the rolling structure and showing its inner stratified structure possessing different cellular populations located into different layers .
- Figure 16 shows the stratified tubular tissue substitute after removal of the rolling structure.
- the device which may possess a closed 1 or open 2 configuration, comprises a lower rectangular part 3, over which a porous membrane 4 is centrally placed.
- a malleable part which can possess a closed 5 or open 6 configuration, defining three contiguous cavities on its lower surface, is placed over the lower rectangular part 3 and over specific zones of the porous membrane 4.
- the malleable part 5 or 6 is compressed against the porous membrane 4.
- the malleable part 5 or 6 defines three cavities on its lower surface, only the extremities and zones situated in between cavities are compressed. In this way, the surfaces submitted to compression become watertight surfaces consequently generating three watertight cavities.
- Tubular structures 9 are added to the closed type malleable part 5) , which pierce its lateral walls and are used for injection, removal and circulation of fluids such as cell suspensions and culture media from/to the interior of the cavities previously delimitated by the device.
- each device cavity should be connected to the exterior by at least two of these tubular structures 9, in a way to allow the entry of fluids and gases through one tubular structure and the simultaneous exit of excess fluids and gases through the other tubular structure. If desired, by simultaneously controlling the entry and exit of fluids and gases, it is possible to exert positive or negative pressures to the interior of each cavity.
- the lower rectangular part 3 is preferably manufactured from polycarbonate or glass.
- the preferential utilization of these materials in the manufacturing of this part is related with their chemical, mechanical and optical properties since they are biologically inert, extremely resistant to solvents, possess good dimensional stability and good resistance to high temperatures.
- the resistance to solvents and high temperatures confers great versatility in terms of the sterilization process to be used since it allows sterilization both through exposure to solvents and to high temperatures (autoclaving) . Additionally, these materials confer an advantage by being transparent, allowing for the content of each cavity to be visualized through the inferior and upper part of the device.
- the malleable parts 5 and 6 are manufactured through a molding process, preferably from silicone.
- silicone is biologically inert, resistant to solvents and to high temperatures. Therefore, these parts can also be sterilized both by exposure to solvents and to high temperatures (autoclaving) . Due to the silicone transparency, these parts allow the content of each cavity to be visualized through its lateral walls, as well as, in the case of the closed malleable part 5, through its upper wall. Additionally, silicone is permeable to gases, enabling the exchange of gases between the culture cavities and the exterior. This feature is particularly important in the case of devices with closed configuration 1.
- the compression part 7 and screws 8 as they do not come into direct contact with the interior of the culture cavities or the porous membrane 4, they do not need to be transparent or inert and can be manufactured from a greater variety of materials, as long as they are dimensionally stable and resistant to solvents and high temperatures .
- the porous membrane 4 should preferably be manufactured from a material or combination of biocompatible and biodegradable materials, which can be processed by various methods, such as electrospinning .
- the size of the membrane pores should also be preferably less than the diameter of cells to be cultured onto the membrane
- the devices herein described can simultaneously contain three different cell cultures (one in each cavity) , which can vary in various ways, such as cellular type and density or culture medium used.
- the device in its closed configuration 1, can be integrated into a culture system illustrated in figure 11.
- This system comprises the device 1 connected to a culture medium reservoir 10 by tubes connected to its tubular structures 9.
- the reservoir 10 In addition to the connections for entry/exit of medium, the reservoir 10 also possesses a further connection for the entry and exit of gases which are purified by an air filter 11.
- the culture medium is collected from the culture medium reservoir 10, pumped by a peristaltic pump 12 to the culture cavity inside the device and finally pumped by the same pump 12 again to the culture medium reservoir 10. This process and apparatus is repeated for each one of the individual culture cavities.
- tubing made from formulations, such as silicone, should preferably used be since they are highly permeable to gases such as carbon dioxide and oxygen, increasing the gas exchange between circulating medium and surrounding atmosphere.
- the system In order to keep a sterile environment, with stable and adequate temperature and humidity, the system is placed inside a cell culture incubator.
- the culture system can be used not only for culture but as well as for the seeding of cells onto membranes for cellular growth. Given its small dimensions, this device requires very low volumes of culture medium. For this reason, it is possible to perform dynamic seeding procedures using highly concentrated cell suspensions without using extremely large amounts of cells. In this way, cells have a greater chance to adhere to the porous membrane's surfaces 4 since they are highly concentrated and are circulated more often through the membrane's surfaces, making the seeding process more efficient.
- the device After sterilization and assembly of the device in its closed 1 or open 2 configuration, containing in its interior an equally sterilized porous membrane by properly compressing its extremities and inter-cavity areas, the device is ready for the start of the cellular seeding over the porous membrane 4 surface.
- -13 substitute sheet Cellular seeding can be performed by different ways depending on the device's configuration.
- a cell suspension can be simply transferred to the interior of the cavities, through their upper apertures, over the porous membrane' s 4 surface. Since there are three contiguous independent cavities, it is possible to transfer suspensions composed of different cell types or combinations of cell types to each one of the cavities.
- the cell suspension should be of sufficient volume to cover the porous membrane' s surface delimitated by each cavity. After having cell suspensions transferred to the cavities, a lid should be placed over the device in order to avoid evaporation.
- the cell suspension When using a closed configuration device 1, the cell suspension is injected into the cavities through one of the tubular structures 9, which connect the cavities to the exterior.
- the injection can be performed using a syringe attached to the external part of the tubular structure.
- the second tubular structure of each cavity should be kept open so that the air, and probably medium excess, are expelled from the chamber and so avoiding excessive pressure. After this procedure all tubular structures should be closed with lids.
- the required time for performing each one of the seeding methods is variable, depending on various factors such as the type of cells use and operator preferences .
- an additional culture medium volume is added to the interior of the cavities or, in case a dynamic seeding/culture system is used, to its culture medium reservoir 10.
- the cell culture period is started. This period can be meant for expansion and/or differentiation, according to the type of supplements included into the culture medium, and can be kept for variable periods of time.
- culture medium should be regularly renewed, totally or partially, according to the intrinsic necessities of each cell type in culture and to the operator' s preferences. This renewal is performed using the same procedures and apparatus as in the seeding step, after total or partial removal of the culture medium contained into the culture cavities and/or dynamic culture fluidic circuit .
- This seeded and cultured porous membrane 13 possessing three different cell types into separate areas of its surface is then rolled around a porous cylindrical or tubular rolling structure 14 in order to generate a stratified tubular structure 15 around that same rolling structure 15.
- the rolling should be initiated from the porous membrane extremity which is closer to the internal cellular colony 16, that is, the cellular colony which should be located in the more internal layers of the generated stratified tubular structure 15.
- the intermediate cellular colony 17 is rolled, which shall be located in the intermediate layers of the stratified tubular structure 15, and finally the external cellular colony 18 which shall be located in the more external layers of the stratified tubular structure 18.
- the rolling tubular structure 14 should preferentially be porous in order to actively or passively allow a more
- the stratified tubular structure 15 should preferably be kept for a certain period of time rolled around the rolling structure 14 and immersed in culture medium in order to allow the cells contained into the various layers to adhere to the surfaces of membranes in adjacent layers.
- some kind of biocompatible adhesive such as, for example fibrin-base sealants, can be applied to the membrane superficial extremities in order to reinforce the formed stratified tubular structure 15 stability.
- the tubular rolling structure 14 is removed from the interior of the stratified tubular structure 15. In this way, a ready-to-use stratified tubular tissue substitute 19 is obtained.
- the porous rolling structure 14 should preferably be manufactured from politetrafluorethylene (PTFE) .
- PTFE politetrafluorethylene
- -17 substitute sheet latter structure.
- PTFE is characterized by its excellent dimensional stability, constant mechanical properties, inertness and biocompatxbxlity. Finally, it shows also great resistance to solvents and to high temperatures being easily sterilizable by use of solvents or by autoclaving.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Sustainable Development (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Clinical Laboratory Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT1060462011 | 2011-12-07 | ||
| PCT/PT2012/000047 WO2013085404A1 (en) | 2011-12-07 | 2012-12-07 | Single-step method and device for the generation of stratified tubular tissue substitutes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP2788469A1 true EP2788469A1 (en) | 2014-10-15 |
Family
ID=51494651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP12813142.2A Withdrawn EP2788469A1 (en) | 2011-12-07 | 2012-12-07 | Single-step method and device for the generation of stratified tubular tissue substitutes |
Country Status (1)
| Country | Link |
|---|---|
| EP (1) | EP2788469A1 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001037884A2 (en) * | 1999-11-22 | 2001-05-31 | Cytograft Tissue Engineering, Inc. | Improved tissue engineered blood vessels and methods and apparatus for their manufacture |
| US20050101010A1 (en) * | 2003-11-10 | 2005-05-12 | Li Albert P. | Cell culture tool and method |
| WO2012032646A1 (en) * | 2010-09-10 | 2012-03-15 | 株式会社島津製作所 | Cell culture device and cell culture method |
-
2012
- 2012-12-07 EP EP12813142.2A patent/EP2788469A1/en not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001037884A2 (en) * | 1999-11-22 | 2001-05-31 | Cytograft Tissue Engineering, Inc. | Improved tissue engineered blood vessels and methods and apparatus for their manufacture |
| US20050101010A1 (en) * | 2003-11-10 | 2005-05-12 | Li Albert P. | Cell culture tool and method |
| WO2012032646A1 (en) * | 2010-09-10 | 2012-03-15 | 株式会社島津製作所 | Cell culture device and cell culture method |
Non-Patent Citations (2)
| Title |
|---|
| DATABASE WPI Week 201222, Derwent World Patents Index; AN 2012-D18505 * |
| See also references of WO2013085404A1 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhao et al. | Bioreactors for tissue engineering: An update | |
| US12527894B2 (en) | Thin film interposition of basement membrane scaffolds | |
| CN103120806B (en) | Preparation method of cartilage framework based on PVA (Polyvinyl Acetate) hydrogel | |
| Lopa et al. | Translational application of microfluidics and bioprinting for stem cell‐based cartilage repair | |
| CN103328625A (en) | Bioreactor | |
| CA2599823A1 (en) | Reverse-flow perfusion of three-dimensional scaffolds | |
| CN1229489C (en) | Device for culturing and/or treating cells | |
| Thangadurai et al. | Emerging perspectives on 3D printed bioreactors for clinical translation of engineered and bioprinted tissue constructs | |
| Partap et al. | Bioreactors in tissue engineering | |
| Mertsching et al. | Bioreactor technology in cardiovascular tissue engineering | |
| EP2800807B1 (en) | Bioreactor composed of watertight chamber and internal matrix for the generation of cellularized medical implants | |
| Visconti et al. | Cardiovascular tissue engineering I. Perfusion bioreactors: a review | |
| Langer | Chemical and biological approaches to regenerative medicine and tissue engineering | |
| Obregón et al. | Bioreactors in tissue engineering | |
| RU137290U1 (en) | DEVICE FOR CREATING TISSUE ENGINEERING DESIGN ON THE BASIS OF TISSUE ENGINEERING MATRIX AND CELL COMPONENTS | |
| Dermenoudis et al. | Bioreactors in tissue engineering | |
| WO2013085404A1 (en) | Single-step method and device for the generation of stratified tubular tissue substitutes | |
| EP2788469A1 (en) | Single-step method and device for the generation of stratified tubular tissue substitutes | |
| CN107988147B (en) | Method for 3D (three-dimensional) epidermis modeling based on organ chip and directed differentiation of induced pluripotent stem cells | |
| EP3138904A1 (en) | Device and method for tissue culture comprising a hermetically sealed blood circulation | |
| Alvarez-Barreto et al. | Tissue engineering bioreactors | |
| Zhao et al. | Advances in skeletal muscle engineering in biomedical research | |
| Kim et al. | Bioreactors in regenerative medicine | |
| TWI421339B (en) | Method of fabricating three dimensional scaffolds and device thereof | |
| He et al. | Advanced tissue engineering strategies for vascularized parenchymal constructs |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20140707 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
| DAX | Request for extension of the european patent (deleted) | ||
| 17Q | First examination report despatched |
Effective date: 20160404 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ASSOCIATION FOR THE ADVANCEMENT OF TISSUE ENGINEER |
|
| RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ASSOCIATION FOR THE ADVANCEMENT OF TISSUE ENGINEER |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20210819 |